Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ASKA Pharmaceutical Holdings Co has a quick ratio of 1.45. It generally indicates good short-term financial strength.
The historical rank and industry rank for ASKA Pharmaceutical Holdings Co's Quick Ratio or its related term are showing as below:
TSE:4886'
s Quick Ratio Range Over the Past 10 Years
Min: 1.38 Med: 1.49 Max: 2.15
Current: 1.45
During the past 5 years, ASKA Pharmaceutical Holdings Co's highest Quick Ratio was 2.15. The lowest was 1.38. And the median was 1.49.
TSE:4886's Quick Ratio is ranked worse than 50.05% of 997
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs TSE:4886: 1.45
ASKA Pharmaceutical Holdings Co (TSE:4886) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
ASKA Pharmaceutical Holdings Co Quick Ratio Related Terms
ASKA Pharmaceutical Holdings Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, ASKA Pharmaceutical Holdings Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ASKA Pharmaceutical Holdings Co Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ASKA Pharmaceutical Holdings Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where ASKA Pharmaceutical Holdings Co's Quick Ratio falls into.
ASKA Pharmaceutical Holdings Co Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASKA Pharmaceutical Holdings Co (TSE:4886) has a Quick Ratio of 1.45 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on ASKA Pharmaceutical Holdings Co and its competitors. This is near median its historical median of 1.49. Over the past decade, ASKA Pharmaceutical Holdings Co's Quick Ratio has ranged from 1.38 to 2.15. According to the industry distribution chart, ASKA Pharmaceutical Holdings Co ranks #499 out of 997 companies in the Drug Manufacturers industry, placing it in the top 50.1%.
Is ASKA Pharmaceutical Holdings Co's Quick Ratio too high?
ASKA Pharmaceutical Holdings Co's current Quick Ratio of 1.45 is near median its 10-year median of 1.49. Over the past 10 years, this metric has ranged from a low of 1.38 to a high of 2.15. The Drug Manufacturers industry median Quick Ratio is 1.45. ASKA Pharmaceutical Holdings Co's value of 1.45 is 0% at this industry median. Based on the distribution chart, ASKA Pharmaceutical Holdings Co ranks #499 out of 997 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, ASKA Pharmaceutical Holdings Co has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ASKA Pharmaceutical Holdings Co's Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, ASKA Pharmaceutical Holdings Co ranks #499 out of 997 companies for Quick Ratio. This places ASKA Pharmaceutical Holdings Co in the lower half of its industry. The industry median Quick Ratio is 1.45. ASKA Pharmaceutical Holdings Co's value of 1.45 is 0% at this benchmark. Historically, ASKA Pharmaceutical Holdings Co's own Quick Ratio has ranged from 1.38 to 2.15 over the past decade. While the company's 10-year median is 1.49 vs. the industry median of 1.45, ASKA Pharmaceutical Holdings Co has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ASKA Pharmaceutical Holdings Co's current Quick Ratio of 1.45 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on ASKA Pharmaceutical Holdings Co and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ASKA Pharmaceutical Holdings Co's current Quick Ratio is 1.45, which is near median its own 10-year median of 1.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASKA Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co (TSE:4886) is currently considered Fairly Valued. The stock's GF Value™ is 円2,402.52, compared to a current price of 円2,244.00 — trading 6.6% below its estimated fair value. The current Quick Ratio is 1.45, which is near median its 10-year median of 1.49 and 0% at the Drug Manufacturers industry median of 1.45. ASKA Pharmaceutical Holdings Co's overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For ASKA Pharmaceutical Holdings Co (TSE:4886), the current Quick Ratio is 1.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ASKA Pharmaceutical Holdings Co (TSE:4886) Overvalued in 2026?
Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co stock appears to be undervalued.
The current stock price of 円2,244.00 is trading 6.6% below its estimated GF Value™ of 円2,402.52.
GuruFocus considers ASKA Pharmaceutical Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4886:
Quick Ratio: 1.45 (near median its 10-year median of 1.49)
GF Value™: 円2,402.52 vs. price of 円2,244.00 (6.6% below fair value)
Industry Position: 0% at the Drug Manufacturers median (#499 of 997)
No single metric tells the full story. See the TSE:4886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ASKA Pharmaceutical Holdings Co Business Description
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and other related operations.
61GF Score
Get the complete analysis for TSE:4886
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4886 has been successfully added to your 
